BNT111 Melanoma Vaccine

Jun 18
5 min read

mRNA Skin Cancer Vaccine Candidate Launches Phase Two Study

BioNTech BNT111 Phase 2 cancer vaccine candidate initiates a clinical study in Europe
protecting skin from the sun
Melanoma